Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news snapshot: IQ-AI, genedrive, Seeing Machines …

A glance at some of the day's highlights from the Proactive Investors newswire

IQ-AI Limited (LON:IQAI) has announced the first commercial sale of its StoneChecker kidney stone medical imaging software.

Rapid diagnostics specialist genedrive PLC (LON:GDR) has raised £5.6mln, net of expenses, through a successful placing of shares and the issue of convertible loan notes. The company said it raised gross proceeds of £3.5mln via a conditional placing of 15,217,391 shares at 23p each – last night’s closing mid-market price – with new and existing investors. In afternoon trading genedrive shares held steady at the 23p level.

Seeing Machines Limited (LON:SEE) has appointed supply chain management specialist Paul McGlone as senior vice president and general manager of the group's fleet division.

Live Company Group Plc (LON:LVCG) have announced the upcoming launch of BRICKLIVE BRICKOSAURS, a new LEGO brick touring show.

Gaming Realms PLC (LON:GMR) wants permission to issue shares if required for a £3.5mln loan owing to mining and casino games group Jackpotjoy. In December last year, Gaming Realms agreed to supply Jackpotjoy with Slingo-based real money services for ten years

Metal Tiger PLC (LON:MTR) has completed the sale of the T3 project in Botswana as well as creating a new joint venture (JV) company formed by itself and partner MOD Resources Limited.

Cadogan Petroleum PLC (LON:CAD) has revealed that as a result of testing the Vovche-2 well has been confirmed as sub-commercial. The company, in a statement, the testing showed the presence of oil though not commercial levels of production.

Chrome producer Afarak Group plc (LON:AFRK) has seen a double-digit rise in revenue in its specialty alloys division so far in 2018. In the first nine months of the year, revenue jumped 11.4% to €72.6mln (30 Sep 17: €65.2mln).

Eland Oil & Gas PLC (LON:ELA) has updated on the field development operations at the Gbetiokun project area, where the initial discovery well has now been re-opened for production. Gbetiokun is to be the second producing oil field in within the OML 40 set of assets, following on from the successes at the Opuama well which is currently producing more than the targeted 30,000 bopd.

Iofina plc (LON:IOF), specialists in the exploration and production of iodine and halogen-based specialty chemical derivatives, announced the appointment of Frank Mermoud as a non-executive director with immediate effect. The group said Mermoud has held senior international, economic and commercial policy positions within the US Government having served as the Secretary of State's Special Representative for Commercial and Business Affairs at US Department of State from 2002 to 2009.

Avation PLC (LON:AVAP) said it has raised £1,999,647 from the proceeds warrant exercises which the company will use for general corporate purposes. The firm said it allotted 1,538,190 fully paid new ordinary shares representing 2.39% of its enlarged share capital under the exercise on the expiry date of the 2015 series staff share warrants, which were originally issued at a price of 130p each.

Horizonte Minerals Plc (LON:HZM) (TSX:HZM) announced that on 15 November, its chief financial officer, Simon Retter purchased 1,000,000 ordinary shares in the company at a price of 2.1p each. Following the purchase, the group said, Retter is now interested in 1,000,000 ordinary shares representing 0.07% of the total voting rights of the company.

MaxCyte (LON:MXCT) (LON:MXCR), the global cell-based medicines and life sciences company, said it will host a webinar, entitled "Non-viral cell engineering: enabling a therapeutic revolution," for investors and sell-side analysts between 15:00 - 16:00 GMT on Tuesday 20th November 2018. To attend, interested parties should contact the company via MaxCyte@consilium-comms.com.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK